Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6EYZ

PI3 kinase delta in complex with 4-Fluorophenyl 5-(4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazol-6-yl)-2-methoxynicotinate

6EYZ の概要
エントリーDOI10.2210/pdb6eyz/pdb
分子名称Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, 2-methoxy-5-[4-[5-[(4-propan-2-ylpiperazin-1-yl)methyl]-1,3-oxazol-2-yl]-2~{H}-indazol-6-yl]pyridine-3-carboxylic acid (3 entities in total)
機能のキーワードcovalent inhibitor, kinase, drug discovery, complex, transferase
由来する生物種Mus musculus (Mouse)
タンパク質・核酸の鎖数1
化学式量合計121327.88
構造登録者
Convery, M.A.,Campos, S.,Dalton, S.E. (登録日: 2017-11-13, 公開日: 2017-12-20, 最終更新日: 2024-11-13)
主引用文献Dalton, S.E.,Dittus, L.,Thomas, D.A.,Convery, M.A.,Nunes, J.,Bush, J.T.,Evans, J.P.,Werner, T.,Bantscheff, M.,Murphy, J.A.,Campos, S.
Selectively Targeting the Kinome-Conserved Lysine of PI3K delta as a General Approach to Covalent Kinase Inhibition.
J. Am. Chem. Soc., 140:932-939, 2018
Cited by
PubMed Abstract: Selective covalent inhibition of kinases by targeting poorly conserved cysteines has proven highly fruitful to date in the development of chemical probes and approved drugs. However, this approach is limited to ∼200 kinases possessing such a cysteine near the ATP-binding pocket. Herein, we report a novel approach to achieve selective, irreversible kinase inhibition, by targeting the conserved catalytic lysine residue. We have illustrated our approach by developing selective, covalent PI3Kδ inhibitors that exhibit nanomolar potency in cellular assays, and a duration of action >48 h in CD4+ T cells. Despite conservation of the lysine residue throughout the kinome, the lead compound shows high levels of selectivity over a selection of lipid and protein kinases in biochemical assays, as well as covalent binding to very few off-target proteins in live-cell proteomic studies. We anticipate this approach could offer a general strategy, as an alternative to targeting non-conserved cysteines, for the development of selective covalent kinase inhibitors.
PubMed: 29232121
DOI: 10.1021/jacs.7b08979
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.2 Å)
構造検証レポート
Validation report summary of 6eyz
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon